专利检索 ap:("VELICEPT THERAPEUTICS, INC.") AND inv:"Raymond E. Stevens, Jr." 第 1 页

1.

发明授权
Compositions and methods of using modified release solabegron for lower urinary tract symptoms 有权

公开(公告)号：US10751311B2

公开(公告)日：2020-08-25

申请号：US15951968

申请日：2018-04-12

申请人： VELICEPT THERAPEUTICS, INC.

发明人： Eliot Ohlstein , Raymond E. Stevens, Jr. , H. Jeffrey Wilkins

IPC分类号： A61K31/196 , A61K9/20 , A61K9/50 , A61K9/16 , A61K9/24 , A61K45/06 , A61K9/00 , A61P31/10

摘要： This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.

2.

发明授权
Compositions and methods of using modified release solabegron for lower urinary tract symptoms 有权

公开(公告)号：US09956194B2

公开(公告)日：2018-05-01

申请号：US14958610

申请日：2015-12-03

申请人： VELICEPT THERAPEUTICS, INC.

发明人： Eliot Ohlstein , Raymond E. Stevens, Jr. , H. Jeffrey Wilkins

IPC分类号： A61K31/196 , A61K9/00 , A61K9/20 , A61K9/24 , A61K45/06 , A61K9/16 , A61K9/50

CPC分类号： A61K31/196 , A61K9/0053 , A61K9/1676 , A61K9/2077 , A61K9/2081 , A61K9/209 , A61K9/5078 , A61K9/5084 , A61K45/06 , A61P31/10

摘要： This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.